{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:58:44Z","timestamp":1761919124946},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T00:00:00Z","timestamp":1216166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10620-008-0359-y","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T21:55:05Z","timestamp":1216158905000},"page":"360-368","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Characteristics of Patients with Hepatitis C Virus-Related Chronic Liver Disease Seropositive for Anticentromere Antibody"],"prefix":"10.1007","volume":"54","author":[{"given":"Takashi","family":"Himoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kinekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Kurokochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Senda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Haba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,16]]},"reference":[{"key":"359_CR1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","volume":"77","author":"Y Moroi","year":"1980","unstructured":"Moroi Y, Peebles C, Flitzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77:1627\u20131631","journal-title":"Proc Natl Acad Sci USA"},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.1780230602","volume":"23","author":"EM Tan","year":"1980","unstructured":"Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 23:617\u2013625","journal-title":"Arthritis Rheum"},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9343(80)90462-3","volume":"69","author":"MJ Fritzler","year":"1980","unstructured":"Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69:520\u2013526","journal-title":"Am J Med"},{"key":"359_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1172\/JCI112320","volume":"77","author":"W Earnshaw","year":"1986","unstructured":"Earnshaw W, Bordwell B, Marino C, Rothfield N (1986) Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 77:426\u2013430","journal-title":"J Clin Invest"},{"key":"359_CR5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1083\/jcb.104.4.817","volume":"104","author":"WC Earnshaw","year":"1987","unstructured":"Earnshaw WC, Sullivan KF, Machlin PS, Cooke CA, Kaiser DA et al (1987) Molecular cloning of cDMA for CENP-B, the major human centromere autoantigen. J Cell Biol 104:817\u2013829","journal-title":"J Cell Biol"},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","volume":"41","author":"RM Berstein","year":"1982","unstructured":"Berstein RM, Callender ME, Neuberger JM, Hughes GRV, Williams R (1982) Anticentromere antibody in primary biliary cirrhosis. Am Rheum Dis 41:612\u2013614","journal-title":"Am Rheum Dis"},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780260714","volume":"26","author":"D Makinenn","year":"1983","unstructured":"Makinenn D, Fritzler M, Davis P, Sherlock S (1983) Anticentromere antibody in primary biliary cirrhosis. Arthritis Rheum 26:914\u2013917","journal-title":"Arthritis Rheum"},{"key":"359_CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","volume":"107","author":"AJ Czaja","year":"1994","unstructured":"Czaja AJ, Nishioka M, Morshed SA, Hachiya T (1994) Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107:200\u2013207","journal-title":"Gastroenterology"},{"key":"359_CR9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2169\/internalmedicine.31.1348","volume":"31","author":"I Shoji","year":"1992","unstructured":"Shoji I, Takagi T, Kasukawa R (1992) Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis. Intern Med 31:1348\u20131355","journal-title":"Intern Med"},{"key":"359_CR10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2957\/kanzo.30.1578","volume":"30","author":"N Yoshida","year":"1989","unstructured":"Yoshida N, Sumino Y, Ueno Y, Shibata M, Sadamoto T, Sato G et al (1989) Clinical significance of anticentromere antibody in primary biliary cirrhosis. Acta Hepatol Jpn 30:1578\u20131583","journal-title":"Acta Hepatol Jpn"},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1386-6346(01)00138-3","volume":"22","author":"J Tojo","year":"2002","unstructured":"Tojo J, Ohira H, Suzuki T, Takeda I, Shoji I et al (2002) Clinicolaboratory characteristics of patients with primary billiary cirrhosis associated with CREST syndrome. Hepatol Res 22:187\u2013195","journal-title":"Hepatol Res"},{"key":"359_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","volume":"55","author":"C Rigamonti","year":"2006","unstructured":"Rigamonti C, Shand LM, Feudjo M, Bunn CC, Black CM, Denton CP et al (2006) Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55:388\u2013394","journal-title":"Gut"},{"key":"359_CR13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2957\/kanzo.28.1164","volume":"28","author":"H Imai","year":"1987","unstructured":"Imai H, Kiyosawa K, Yamaguchi K, Furuta S, Okumura N, Kumagai T et al (1987) The clinical significance of anticentromere antibodies (ACA) in sera of patients with autoimmune liver disease. Acta Hepatol Jpn 28:1164\u20131171","journal-title":"Acta Hepatol Jpn"},{"key":"359_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","volume":"18","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA (1993) Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 18:342\u2013352","journal-title":"J Hepatol"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01316792","volume":"38","author":"MW Fried","year":"1993","unstructured":"Fried MW, Draguesku JO, Shindo M, Simpson LH, Banks SM, Hoofnagle JH et al (1993) Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 38:631\u2013636","journal-title":"Dig Dis Sci"},{"key":"359_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0168-8278(05)80281-8","volume":"18","author":"N Abuaf","year":"1993","unstructured":"Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R et al (1993) Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 18:359\u2013364","journal-title":"J Hepatol"},{"key":"359_CR17","first-page":"613","volume":"21","author":"BD Clifford","year":"1995","unstructured":"Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M et al (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613\u2013619","journal-title":"Hepatology"},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","volume":"26","author":"F Cassani","year":"1997","unstructured":"Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R et al (1997) Serum antoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26:561\u2013566","journal-title":"Hepatology"},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","volume":"26","author":"M Nishioka","year":"1997","unstructured":"Nishioka M, Morshed SM, Kono K, Himoto T, Parveen S, Arima K et al (1997) Frequency and significance of antibodies to p450 IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol 26:992\u20131000","journal-title":"J Hepatol"},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","volume":"45","author":"M Lenzi","year":"1999","unstructured":"Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L et al (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45:435\u2013441","journal-title":"Gut"},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00004836-200111000-00012","volume":"33","author":"YC Peng","year":"2001","unstructured":"Peng YC, Hsieh SC, Yang DY, Tung CF, Hu WH, Huang WN, Chen GH (2001) Expression and clinical significance of antinuclear antibody in hepatitis C virus infection. J Clin Gastroenterol 33:402\u2013406","journal-title":"J Clin Gastroenterol"},{"key":"359_CR22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2893.2004.00530.x","volume":"11","author":"LJ Yee","year":"2004","unstructured":"Yee LJ, Goldin KRD, Marshall S, Thomas HC, Alberti A, Chiaramonte M et al (2004) Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. J Vir Hepat 11:459\u2013464","journal-title":"J Vir Hepat"},{"key":"359_CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1086\/427285","volume":"40","author":"P Muratori","year":"2005","unstructured":"Muratori P, Muratori L, Guidi M, Granito A, Susca M, Lenzi M, Bianchi FB (2005) Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 40:501\u2013507","journal-title":"Clin Infect Dis"},{"key":"359_CR24","doi-asserted-by":"crossref","unstructured":"Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ et al (2008) The antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in chronic hepatitis C patients. J Clin Pathol 61:333\u2013337","DOI":"10.1136\/jcp.2006.046276"},{"key":"359_CR25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","volume":"19","author":"JM Pawlotsky","year":"1994","unstructured":"Pawlotsky JM, Yahia MB, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F et al (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19:841\u2013848","journal-title":"Hepatology"},{"key":"359_CR26","doi-asserted-by":"crossref","unstructured":"Manns MP, Rambusch EG (1999) Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 31[Suppl1]:39\u201342","DOI":"10.1016\/S0168-8278(99)80372-9"},{"key":"359_CR27","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/JCM.31.10.2679-2682.1993","volume":"31","author":"KE Sherman","year":"1993","unstructured":"Sherman KE, O\u2019Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P et al (1993) Quantitative evaluation of hepatitis C virus in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 31:2679\u20132682","journal-title":"J Clin Microbiol"},{"key":"359_CR28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0140-6736(93)90635-T","volume":"341","author":"JY Lau","year":"1993","unstructured":"Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS et al (1993) Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501\u20131504","journal-title":"Lancet"},{"key":"359_CR29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840190538","volume":"19","author":"P Simmonds","year":"1994","unstructured":"Simmonds P, Alberti A, Alter HJ, Bomino F, Bradley DW, Brechot C et al (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321\u20131324","journal-title":"Hepatology"},{"key":"359_CR30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","volume":"6","author":"F Ichida","year":"1996","unstructured":"Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T et al (1996) New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6:112\u2013119","journal-title":"Int Hepatol Commun"},{"key":"359_CR31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431\u2013435","journal-title":"Hepatology"},{"key":"359_CR32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hep.1840150403","volume":"15","author":"N Bach","year":"1992","unstructured":"Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15:572\u2013577","journal-title":"Hepatology"},{"key":"359_CR33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.1840150402","volume":"15","author":"PJ Scheuer","year":"1992","unstructured":"Scheuer PJ, Ashrafzadeh P, Sherlock S, Bromn D, Dusheiko GM (1992) The pathology of hepatitis C. Hepatology 15:567\u2013571","journal-title":"Hepatology"},{"key":"359_CR34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0016-5085(93)90432-C","volume":"104","author":"JH Lefkowitch","year":"1993","unstructured":"Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC et al (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis C. Gastroenterology 104:595\u2013603","journal-title":"Gastroenterology"},{"key":"359_CR35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1007264","volume":"15","author":"ZD Goodman","year":"1995","unstructured":"Goodman ZD, Ishak KG (1995) Histopathology of hepatitis C virus infection. Sem Liver Dis 15:70\u201381","journal-title":"Sem Liver Dis"},{"key":"359_CR36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.510260229","volume":"26","author":"A Czaja","year":"1997","unstructured":"Czaja A, Carpenter HA (1997) Histological findings in chronic hepatitis C with autoimmune features. Hepatology 26:459\u2013466","journal-title":"Hepatology"},{"key":"359_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.1840220203","volume":"22","author":"MA Freni","year":"1995","unstructured":"Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N et al (1995) Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 22:389\u2013394","journal-title":"Hepatology"},{"key":"359_CR38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughts AK, Cancado EL et al (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"359_CR39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajcp\/69.2.103","volume":"69","author":"PI Terasaki","year":"1978","unstructured":"Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y (1978) Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 69:103\u2013120","journal-title":"Am J Clin Pathol"},{"key":"359_CR40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10875-006-9038-y","volume":"26","author":"B Bonaci-Nikolic","year":"2006","unstructured":"Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M (2006) Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol 26:438\u2013446","journal-title":"J Clin Immunol"},{"key":"359_CR41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2893.2005.00642.x","volume":"12","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Pares A, Jara LJ, Solans R, Ninas O, Vazquez P et al (2005) Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. J Viral Hepat 12:648\u2013654","journal-title":"J Viral Hepat"},{"key":"359_CR42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","volume":"49","author":"JD Riveille","year":"2003","unstructured":"Riveille JD, Solomon DH (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl\u201370, and nucleolar antibodies. Arthritis Rheum 49:399\u2013412","journal-title":"Arthritis Rheum"},{"key":"359_CR43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7326\/0003-4819-95-4-431","volume":"95","author":"MB Gordon","year":"1981","unstructured":"Gordon MB, Klein I, Dekker A, Rodnan G, Medsger TA (1981) Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 95:431\u2013435","journal-title":"Ann Intern Med"},{"key":"359_CR44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00262092","volume":"14","author":"P Caramaschi","year":"1995","unstructured":"Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM (1995) Anticentromere antibody-clinical associations a study of 44 patients. Rheumatol Int 14:253\u2013255","journal-title":"Rheumatol Int"},{"key":"359_CR45","first-page":"2238","volume":"28","author":"K Katano","year":"2001","unstructured":"Katano K, Kawano M, Koni I, Sugai S, Muro Y (2001) Clinical and laboratory features of anticentromere antibody positive primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 28:2238\u20132244","journal-title":"J Rheumatol"},{"key":"359_CR46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0039.1994.tb02375.x","volume":"44","author":"M Hashimoto","year":"1994","unstructured":"Hashimoto M, Kinoshita T, Yamasaki M, Tanaka H, Imanishi T, Ihara H et al (1994) Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 44:166\u2013173","journal-title":"Tissue Antigens"},{"key":"359_CR47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000198892","volume":"26","author":"H Miyamori","year":"1983","unstructured":"Miyamori H, Kato Y, Kobayashi K, Hattori N (1983) HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 26:213\u2013217","journal-title":"Digestion"},{"key":"359_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0016-5085(92)90069-B","volume":"103","author":"T Maeda","year":"1992","unstructured":"Maeda T, Onishi S, Saibara T, Iwasaki S, Yamamoto Y (1992) HLA DRw8 and primary biliary cirrhosis. Gastroenterology 103:118\u2013119","journal-title":"Gastroenterology"},{"key":"359_CR49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","volume":"33","author":"E Genth","year":"1990","unstructured":"Genth E, Mierau R, Genetzky P, von Muhlen CA, Kaufmann S, von Wilmowsky H et al (1990) Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 33:657\u2013665","journal-title":"Arthritis Rheum"},{"key":"359_CR50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.54.12.983","volume":"54","author":"M Kuwana","year":"1995","unstructured":"Kuwana M, Okano Y, Kaburaki J, Inoko H (1995) HLA class II genes associated with anticentromere antibody in Japanese patients with systemic scleroisis (scleroderma). Ann Rheum Dis 54:983\u2013987","journal-title":"Ann Rheum Dis"},{"key":"359_CR51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2177\/jsci.16.208","volume":"16","author":"K Onami","year":"1993","unstructured":"Onami K, Moteki S, Yoshida H, Kasukawa R (1993) Human leukocyte antigen (HLA) in cases of CREST syndrome and PBC-CREST overlap syndrome reported in Japan. Jpn J Clin Immun 16:208\u2013215","journal-title":"Jpn J Clin Immun"},{"key":"359_CR52","first-page":"407","volume":"14","author":"SF Pan","year":"1971","unstructured":"Pan SF, Rodnan GP, Wald N (1971) Chromosonal abnormalities in progressive systemic sclerosis (scleroderma). Arthritis Rheum 14:407\u2013408","journal-title":"Arthritis Rheum"},{"key":"359_CR53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2177\/jsci.27.397","volume":"27","author":"A Aoki","year":"2004","unstructured":"Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S (2004) Liver involvement in primary Sj\u00f6gren\u2019s syndrome. Jpn J Clin Immunol 27:397\u2013401","journal-title":"Jpn J Clin Immunol"},{"key":"359_CR54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2249.2000.01189.x","volume":"120","author":"Y Muro","year":"2000","unstructured":"Muro Y, Azuma N, Onouchi H, Kunimatsu M, Tomita Y, Sasaki M et al (2000) Autoepitopes on autoantigen centromere protein-A (CENP-A) are restricted to the N-terminal region, which has no homology with histone H3. Clin Exp Immunol 120:218\u2013223","journal-title":"Clin Exp Immunol"},{"key":"359_CR55","first-page":"142","volume":"27","author":"K Russo","year":"2000","unstructured":"Russo K, Hoch S, Dima C, Varga J, Teodorescu M (2000) Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 27:142\u2013147","journal-title":"J Rheumatol"},{"key":"359_CR56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118\u2013127","journal-title":"Hepatology"},{"key":"359_CR57","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","volume":"2","author":"WH Yang","year":"2004","unstructured":"Yang WH, Yu JH, Nakajima A, Neuberg D, Lindor K, Bloch DB (2004) Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol 2:1116\u20131122","journal-title":"Clin Gastroenterol Hepatol"},{"key":"359_CR58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s100670050029","volume":"19","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K (2000) Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 19:123\u2013126","journal-title":"Clin Rheumatol"},{"key":"359_CR59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-044450331-2\/50018-7","volume-title":"Cancer and autoimmunity","author":"K Conrad","year":"2000","unstructured":"Conrad K (2000) Autoantibodies in cancer patients and in persons with a higher risk of cancer development. In: Shoenfeld Y, Gershwin MF (eds) Cancer and autoimmunity. Elsevier, Amsterdam, pp 159\u2013174"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0359-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0359-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:24:16Z","timestamp":1588814656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,16]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0359-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,16]]}}}